Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
New heart device makes US debut | CT-based extracellular volume assessments | Canon launches TAVR tech | Riverrain & RapidAI
Wednesday, October 7, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Cardiologist performs first US implant of new heart device

The Acticor Sky CRT-DX, which secured FDA approval in April, has officially made its debut in the United States.

READ MORE >
 The U.S. Food and Drug Administration (FDA) has granted market clearance for Biotronik's Acticor Sky and Rivacor Sky implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems. The new technology will be launches at the Heart Rhythm Society (HRS) annual meeting this week. #HRS2026
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist performs first US implant of new heart device

Share on Twitter Share on Facebook Share on Linkedin
 The U.S. Food and Drug Administration (FDA) has granted market clearance for Biotronik's Acticor Sky and Rivacor Sky implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems. The new technology will be launches at the Heart Rhythm Society (HRS) annual meeting this week. #HRS2026
The Acticor Sky CRT-DX, which secured FDA approval in April, has officially made its debut in the United States.
READ MORE >

Extracellular volume assessments can make cardiac CT more valuable than ever

MRI scans have traditionally been used for extracellular volume assessments. That is starting to change, however, as cardiac CT moves beyond its typical focus on the coronary arteries.

READ MORE >
Amit Patel, MD, FSCCT, director of cardiac imaging, and a professor of medicine at the University of Virginia Health System, Charlottesville, explains how extracellular volume (ECV) is being used increasingly in cardiac CT to visualize structural remodeling and conditions like diffuse myocardial fibrosis, amyloidosis, or edema.
Share on Twitter Share on Facebook Share on Linkedin

Extracellular volume assessments can make cardiac CT more valuable than ever

Share on Twitter Share on Facebook Share on Linkedin
Amit Patel, MD, FSCCT, director of cardiac imaging, and a professor of medicine at the University of Virginia Health System, Charlottesville, explains how extracellular volume (ECV) is being used increasingly in cardiac CT to visualize structural remodeling and conditions like diffuse myocardial fibrosis, amyloidosis, or edema.
MRI scans have traditionally been used for extracellular volume assessments. That is starting to change, however, as cardiac CT moves beyond its typical focus on the coronary arteries.
READ MORE >

Canon launches new TAVR technology to help structural heart programs meet rising demand

TAVR Assist+ was built to capture patient measurements and perform other straightforward tasks. This gives cardiologists more time to make critical treatment decisions.

READ MORE >
Canon Medical Informatics TAVR Assist+
Share on Twitter Share on Facebook Share on Linkedin

Canon launches new TAVR technology to help structural heart programs meet rising demand

Share on Twitter Share on Facebook Share on Linkedin
Canon Medical Informatics TAVR Assist+
TAVR Assist+ was built to capture patient measurements and perform other straightforward tasks. This gives cardiologists more time to make critical treatment decisions.
READ MORE >

FDA-cleared cardiothoracic imaging tools being added to popular AI platform

Ohio-based Riverain Technologies is now making its FDA-cleared suite of AI tools available through RapidAI’s Rapid Enterprise Platform.

READ MORE >
AI handshake
Share on Twitter Share on Facebook Share on Linkedin

FDA-cleared cardiothoracic imaging tools being added to popular AI platform

Share on Twitter Share on Facebook Share on Linkedin
AI handshake
Ohio-based Riverain Technologies is now making its FDA-cleared suite of AI tools available through RapidAI’s Rapid Enterprise Platform.
READ MORE >

Featured Articles

A Practical Guide to Cardiovascular Strategic Planning for Better Care Delivery

Sponsored by MedAxiom

For hospitals, health systems and physician groups, effective cardiovascular strategic planning is the foundation for better cardiovascular care delivery, stronger service line performance and sustainable program growth. This article offers a practical approach for cardiovascular leaders who want a service line strategy that is more than a document.

READ MORE >
Strategic planning meeting
Share on Twitter Share on Facebook Share on Linkedin

A Practical Guide to Cardiovascular Strategic Planning for Better Care Delivery

Sponsored by MedAxiom

Share on Twitter Share on Facebook Share on Linkedin
Strategic planning meeting
For hospitals, health systems and physician groups, effective cardiovascular strategic planning is the foundation for better cardiovascular care delivery, stronger service line performance and sustainable program growth. This article offers a practical approach for cardiovascular leaders who want a service line strategy that is more than a document.
READ MORE >

CMS considers covering TAVR for aortic regurgitation

CMS just finalized major updates to its TAVR coverage policies. Could even more change be on the horizon? 

READ MORE >
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Share on Twitter Share on Facebook Share on Linkedin

CMS considers covering TAVR for aortic regurgitation

Share on Twitter Share on Facebook Share on Linkedin
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
CMS just finalized major updates to its TAVR coverage policies. Could even more change be on the horizon? 
READ MORE >

FDA approves updates to Abbott’s CardioMEMS heart failure platform

Heart failure patients with a CardioMEMS implant can now monitor their own pulmonary artery pressure readings and receive clinician feedback through a smartphone app.

READ MORE >
CardioMEMS Abbott heart failure
Share on Twitter Share on Facebook Share on Linkedin

FDA approves updates to Abbott’s CardioMEMS heart failure platform

Share on Twitter Share on Facebook Share on Linkedin
CardioMEMS Abbott heart failure
Heart failure patients with a CardioMEMS implant can now monitor their own pulmonary artery pressure readings and receive clinician feedback through a smartphone app.
READ MORE >

American Heart Association celebrates high-quality outpatient care

The AHA recognized more than 2,700 U.S. healthcare organizations for managing patients with high blood pressure, high cholesterol and/or type 2 diabetes. 

READ MORE >
Doctor patient
Share on Twitter Share on Facebook Share on Linkedin

American Heart Association celebrates high-quality outpatient care

Share on Twitter Share on Facebook Share on Linkedin
Doctor patient
The AHA recognized more than 2,700 U.S. healthcare organizations for managing patients with high blood pressure, high cholesterol and/or type 2 diabetes. 
READ MORE >

A big win for Foundayo: GLP-1 pill orforglipron helps patients lose weight, protect their hearts

Orforglipron was linked to consistent weight loss in addition to reductions in waist circumference, systolic blood pressure, triglycerides, non-HDL cholesterol and high-sensitivity C-reactive protein. In terms of safety, it was found to be noninferior to insulin glargine.

READ MORE >
doctor with overweight patient who may be treated with TAVR or surgery
Share on Twitter Share on Facebook Share on Linkedin

A big win for Foundayo: GLP-1 pill orforglipron helps patients lose weight, protect their hearts

Share on Twitter Share on Facebook Share on Linkedin
doctor with overweight patient who may be treated with TAVR or surgery
Orforglipron was linked to consistent weight loss in addition to reductions in waist circumference, systolic blood pressure, triglycerides, non-HDL cholesterol and high-sensitivity C-reactive protein. In terms of safety, it was found to be noninferior to insulin glargine.
READ MORE >

In Case You Missed It

Late-breaking clinical trials announced for TCT 2026 in San Diego

TCT 2026 will include a full schedule of late-breaking studies focused on minimally invasive interventions, pharmaceutics, structural heart disease and much more.

READ MORE >
TCT late breaking trial presentation in the main arena at TCT 2025. Photo by Michael Walter
Share on Twitter Share on Facebook Share on Linkedin

Late-breaking clinical trials announced for TCT 2026 in San Diego

Share on Twitter Share on Facebook Share on Linkedin
TCT late breaking trial presentation in the main arena at TCT 2025. Photo by Michael Walter
TCT 2026 will include a full schedule of late-breaking studies focused on minimally invasive interventions, pharmaceutics, structural heart disease and much more.
READ MORE >

WVU Heart and Vascular Institute, a known leader in cardiac surgery, celebrates a decade of success

The WVU Heart and Vascular Institute was founded in 2016 to help advance the diagnosis, management and treatment of cardiovascular disease. It is now nationally recognized for delivering high-quality care in addition to being a world leader in robotic cardiac surgery.

READ MORE >
West Virginia University (WVU) is celebrating a significant milestone: the 10-year anniversary of the WVU Heart and Vascular Institute.
Share on Twitter Share on Facebook Share on Linkedin

WVU Heart and Vascular Institute, a known leader in cardiac surgery, celebrates a decade of success

Share on Twitter Share on Facebook Share on Linkedin
West Virginia University (WVU) is celebrating a significant milestone: the 10-year anniversary of the WVU Heart and Vascular Institute.
The WVU Heart and Vascular Institute was founded in 2016 to help advance the diagnosis, management and treatment of cardiovascular disease. It is now nationally recognized for delivering high-quality care in addition to being a world leader in robotic cardiac surgery.
READ MORE >

Key things to consider when building the team for your cardiac CT program

Getting nurses and technologists more involved is a smart way to ensure new cardiac CT programs deliver the safest, most effective patient care possible.

READ MORE >
Video: Brennen Johnston, BASRT(R)(CT) ARRT. Radiology Director of Enterprise Advanced Cardiac Imaging for Advocate Health in Charlotte, N.C., explains the role of a CCTA technologist champion when implementing or expanding new cardiac CT programs. #SCCT #YesCCT
Share on Twitter Share on Facebook Share on Linkedin

Key things to consider when building the team for your cardiac CT program

Share on Twitter Share on Facebook Share on Linkedin
Video: Brennen Johnston, BASRT(R)(CT) ARRT. Radiology Director of Enterprise Advanced Cardiac Imaging for Advocate Health in Charlotte, N.C., explains the role of a CCTA technologist champion when implementing or expanding new cardiac CT programs. #SCCT #YesCCT
Getting nurses and technologists more involved is a smart way to ensure new cardiac CT programs deliver the safest, most effective patient care possible.
READ MORE >

In Other News

GE Healthcare to acquire radiopharma firm Sofie Biosciences for $945M

The Chicago-based imaging systems manufacturer will pay the purchase price in cash, acquiring the company from private equity firm Trilantic North America. 

READ MORE >
Radiopharmaceutical manufacturing at a SOFIE Biosciences site
Share on Twitter Share on Facebook Share on Linkedin

GE Healthcare to acquire radiopharma firm Sofie Biosciences for $945M

Share on Twitter Share on Facebook Share on Linkedin
Radiopharmaceutical manufacturing at a SOFIE Biosciences site
The Chicago-based imaging systems manufacturer will pay the purchase price in cash, acquiring the company from private equity firm Trilantic North America. 
READ MORE >

Should traditional Medicare emulate Medicare Advantage by capping patients’ out-of-pocket maximums?

Answer to the headline above: Only if traditional Medicare (TM) beneficiaries for Parts A and B would be OK with $10,000 as the cap and taxpayers don’t mind footing a bigger bill for Medicare. 

READ MORE >
older lady woman gal
Share on Twitter Share on Facebook Share on Linkedin

Should traditional Medicare emulate Medicare Advantage by capping patients’ out-of-pocket maximums?

Share on Twitter Share on Facebook Share on Linkedin
older lady woman gal
Answer to the headline above: Only if traditional Medicare (TM) beneficiaries for Parts A and B would be OK with $10,000 as the cap and taxpayers don’t mind footing a bigger bill for Medicare. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Previewing TCT 2026 | FDA clears new AI tool | First procedure of its kind performed in US | Intravascular imaging & PCI
The world's best heart hospitals | New CVD trends | Real-world thrombectomy data | AHA Scientific Sessions 2026
TAVR Highlights: Medicare covers asymptomatic patients | More policy changes on the way? | AI's impact | The risk of waiting
New heart device makes US debut | CT-based extracellular volume assessments | Canon launches TAVR tech | Riverrain & RapidAI
Semaglutide & the heart | Pro athlete sues doctors | BP drug recalled | GLP-1 pill makes a difference | A new CVD risk factor
CMS may cover TAVR for aortic regurgitation | FDA approves CardioMEMS updates | Lilly's GLP-1 pill | Celebrating outpatient care
September's Top Stories: BP drug recalled | Major TAVR changes | AI for heart attack detection | FDA approves small pacemaker
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup